BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help
Search Results
Documents 1-2 out of 2 found
  Current Search:  serostim: 2     
HTML
100%
Tesamorelin Diminished Gut Fat in Phase 3 Study
The Canadian company Theratechnologies announced Monday that its experimental drug tesamorelin reduced belly fat accumulation by 18 percent over 52 weeks in the second of two Phase 3 clinical trials.

And in a second announcement on Tuesday...

AIDSmeds:  Dec 18 2008 7:19AM
Matching: serostim 		Find similar documents
HTML
100%
Tesamorelin Diminished Gut Fat in Phase 3 Study
The Canadian company Theratechnologies announced Monday that its experimental drug tesamorelin reduced belly fat accumulation by 18 percent over 52 weeks in the second of two Phase 3 clinical trials.

And in a second announcement on Tuesday...

POZ.com:  Dec 18 2008 3:26AM
Matching: serostim 		Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.